
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1200 | 1050 | 1258 | 1372 | 1373 | 2115 |
Fund Return | 20.02% | 4.99% | 25.82% | 11.11% | 6.54% | 7.78% |
Place in category | 735 | 775 | 779 | 440 | 1012 | 715 |
% in Category | 67 | 69 | 70 | 41 | 99 | 89 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Deutsche Core Equity S | 3.54B | -6.69 | 10.20 | 11.13 | ||
Deutsche Science and Technology A | 1.3B | -10.29 | 18.61 | 16.81 | ||
Deutsche Capital Growth S | 1.12B | -6.78 | 12.77 | 13.22 | ||
Deutsche S&P 500 Index S | 1.02B | -5.01 | 11.86 | 12.02 | ||
Deutsche Capital Growth VIP Class A | 1.01B | -6.75 | 12.95 | 13.47 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Dodge & Cox Stock | 64.11B | -0.06 | 10.12 | 10.68 | ||
Vanguard Equity-Income Adm | 50.9B | -0.18 | 8.33 | 9.86 | ||
Vanguard Windsor II Admiral | 45.17B | -2.89 | 9.22 | 9.94 | ||
American Funds American Mutual A | 40.71B | 0.23 | 8.04 | 9.25 | ||
Vanguard Value Index Adm | 36.28B | -1.00 | 8.48 | 9.77 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Kellanova | US4878361082 | 3.36 | 82.39 | +0.38% | |
Medtronic | IE00BTN1Y115 | 2.73 | 80.68 | -0.28% | |
Cummins | US2310211063 | 2.67 | 317.23 | -1.42% | |
Bank of NY Mellon | US0640581007 | 2.64 | 89.09 | -0.10% | |
ONEOK | US6826801036 | 2.63 | 81.14 | -0.28% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review